Emerge
Posts
🚀 Trump signs Executive Order to support crypto

🚀 Trump signs Executive Order to support crypto

Liam Gill
January 27, 2025

In partnership with

See your finances more clearly with BILL & Ray-Bans

Over 60% of finance leaders that we surveyed this year said that financial automation helps them see a clearer picture of their financial operations.

Choose BILL Spend & Expense and get:

Real-time visibility and great rewards
Fraud protections
Automated expense reporting for your business

Plus, get a pair of Ray-Ban Smart Glasses when you demo BILL.¹ Ready to see clearly for 2025?

Request a demo

¹ Terms & Conditions Apply. See offer page for more details. The BILL Divvy Card is issued by Cross River Bank, Member FDIC, and is not a deposit product.

Market Overview
Read time 1.4 minutes

Year To Date Performances:

Dow Jones	44,565.07	4.75%
S&P 500	6,118.71	4.03%
Nasdaq	20,053.68	3.85%
Russell 2000	2,314.60	3.79%
TSX	25,434.08	2.86%
Bitcoin	$105,170.80	12.50%
Ethereum	$3,398.12	1.92%
US to Canadian Dollar	$1.43	-0.16%

President Donald Trump, once a critic of cryptocurrencies, has taken a sharp turn by signing an executive order to bolster the U.S. crypto industry, including exploring a national digital asset stockpile. The move signals a broader shift in his administration's stance, appointing pro-crypto leaders like David Sacks as a key advisor, nominating Paul Atkins for SEC chair, and championing innovation-friendly policies. The order outlines protections for blockchain developers, miners, and self-custody advocates while emphasizing stablecoin growth to strengthen U.S. dollar sovereignty. With crypto donations playing a significant role in Trump’s 2024 campaign, this strategy positions the U.S. as a global hub for digital asset innovation.
Novo Nordisk shares surged nearly 14% after promising early-stage results from its amycretin obesity drug trial showed an average weight loss of 22% in overweight and obese patients over 36 weeks, far outperforming the 2% weight gain seen with placebo. Amycretin, which targets gut and pancreas hormones affecting hunger, joins Novo’s flagship drug Wegovy in leveraging GLP-1 pathways. With mild-to-moderate gastrointestinal side effects reported, the findings bolster the drug's potential, alongside an oral version showing 13.1% weight loss in a separate trial. Competitors like Zealand Pharma also saw gains, while Eli Lilly faced minor pre-market dips.
Use SEO to reach red-hot buyers before the competition with Ignite Digital. There are 8.5 billion searches per day on Google. Are you showing up? If not then you’re losing sales. Ignite Digital are the SEO experts with 13 years of experience. Request a FREE competitive analysis and Ignite Digital will respond on the same day with a sneak peek of your competitor’s strategy & how you can beat them.*
Tesla has launched the revamped Model Y Juniper in the U.S., priced at $59,990 before a $7,500 federal EV tax credit, with deliveries set to begin in March. The updated SUV boasts design enhancements, ventilated and reclining seats, and improved Wi-Fi. Tesla, grappling with 2024’s delivery decline, hopes the new model will bolster its core automotive business amid growing EV competition. However, uncertainty looms as President Trump, backed by Elon Musk, considers repealing the federal EV tax credit—a move that could disrupt the industry. Tesla's brand perception has also been impacted by Musk's political ties and aging vehicle lineup.
Headlines
1. The UK is reducing the tax burden for high-net-worth foreigners after seeing a significant exodus of wealthy individuals in recent years.
2. Singapore has eased its monetary policy for the first time since 2020, claiming that the move was made due to an anticipated decline in global growth.
_{* This is sponsored content.}

Are you looking to grow your business? Here is how I can help:

📱Book a Strategy Call to get 1:1 feedback on your pitch, pitch deck and/or fundraising strategy. (If you need general startup advice, then reply to this email, and I’ll let you know if/how I can help.)